SAM-e for Cellular Health
SAM-e is the body main methyl donor, but supplementing it has not been shown to improve general cellular health markers.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- Studied at 400-1,600 mg/day for depression and osteoarthritis; no cellular health outcome has been measured
- Expected timeframe
- Not established
Protocol
- form
- Enteric-coated S-adenosyl-L-methionine, butanedisulfonate or tosylate salt; SAM-e is unstable and degrades with heat and moisture
- duration
- Not applicable
- co factor
- Evidence is insufficient. SAM-e is the universal methyl donor in human metabolism, participating in more than 100 methylation reactions covering DNA, phospholipids, neurotransmitters and proteins, and it feeds glutathione synthesis through the transsulfuration pathway - so the cellular biology is genuinely central. That does not make cellular health a measurable outcome. No trial has assessed methylation status, glutathione levels, mitochondrial function or any cellular endpoint after SAM-e supplementation in healthy people, and the clinical evidence base is confined to depression, osteoarthritis and liver disease.
- titration
- Not applicable - no dose-response for cellular endpoints has been established
- starting dose
- Not established for this outcome. Trials used 400-1,600 mg/day of SAM-e for depression and 1,200 mg/day for osteoarthritis
Evidence
What the studies say
No studies are yet linked to both SAM-e and Cellular Health.
Safety
Caveats
The methylation pathway is genuinely important, and where it matters clinically it is assessed properly: homocysteine, B12, folate and in some contexts MMA are the relevant tests, and elevated homocysteine is corrected with B12, folate and B6 rather than SAM-e. Direct-to-consumer methylation panels and MTHFR genotype testing are not recommended by genetics professional bodies for guiding supplementation, and MTHFR variants are common and generally not clinically actionable. Safety of SAM-e: the main concern is that it can precipitate hypomania or mania, so it must be avoided in bipolar disorder and in anyone with a family history suggestive of it. It is serotonergic, so it should not be combined with SSRIs, SNRIs, MAO inhibitors, tramadol, triptans or St John wort without medical advice, given serotonin syndrome risk. It can cause nausea, insomnia, anxiety and gastrointestinal upset, particularly at higher doses, and should be taken in the morning. Safety in pregnancy and breastfeeding is not established. It should be used with a B12 and folate source, since SAM-e metabolism generates homocysteine.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.